Med-El loses UK appeal in Advanced Bionics fight

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Med-El loses UK appeal in Advanced Bionics fight

Entrance to the Royal Court of Justice

The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor

Hearing implant maker Med-El lost an appeal in its patent fight with Advanced Bionics at the England and Wales Court of Appeal today, May 24.

Lady Justice Kathryn Thirlwall, who handed down the judgment, also had sharp words for Med-El’s representatives over a reference to a deputy High Court judge’s background as a solicitor.

Med-El had challenged the High Court’s decision, issued by Mr Justice Campbell Forsyth in June 2022, to invalidate one of its patents covering cochlear implants.

Arguments began yesterday, May 23, and finished this morning.

The court, which dismissed Med-El’s appeal in full, handed down its verdict this afternoon.

Thirlwall heard the appeal alongside Lord Justices Richard Arnold and Colin Birss.

The full judgment has yet to be published, but Managing IP attended a virtual hand down.

According to Med-El’s counsel, Forsyth made an error in finding the patent obvious over a piece of prior art.

The prior art in question was another patent covering the design of cochlear implants and referred to as ‘Zimmerling’.

Sharp rebuke

At the end of proceedings, Thirlwall criticised Med-El’s representatives over how they referred to Forsyth in their skeleton argument.

The document referred to Forsyth’s job as a partner at Mishcon de Reya and noted that he was appointed to sit as a deputy High Court judge in late 2021.

Thirlwall said these details were irrelevant and “raised eyebrows” among the judges.

“Those matters shouldn’t have been in the skeleton argument.

“It’s no more appealing to do that than to say it was a very strong court,” she told Adrian Speck KC, who argued for Med-El.

Speck said the brief was only meant to identify the judge.

But Thirlwall replied: “His name would have done, and we had that on the judgment.

“I wouldn’t expect to see that sort of observation made in anyone’s skeletons before this court.”

In its own skeleton, Advanced Bionics criticised Med-El for highlighting Forsyth’s training as a solicitor.

“They could also have pointed out that he is a patent specialist of many years’ standing,” the Advanced Bionics brief said.

Solicitor judges are rare in England and Wales, where most High Court judges are former barristers.

An EPO board of appeal upheld an amended version of Med-El’s patent last September.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article